Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Active Shortage

HISTATROL

ALK-ABELLO INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of HISTATROL in Canada?

Yes. HISTATROL 2.75MG has an active shortage reported to Health Canada (last updated December 8, 2025).

Why is HISTATROL not available?

The reason the manufacturer reported: Shortage of an active ingredient.

When will HISTATROL be available again?

The manufacturer's estimated resolution date is December 31, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusActive Shortage
Same-ingredient products on file2 products
Expected resolution~3 months remaining (estimate)
Affected strength2.75MG
Last updated2025-12-08

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

HISTAMINE PHOSPHATE INJECTION USP LIQ SC

BIONICHE PHARMA (CANADA) LTD

1MG · DIN 02094673

Different strengthDifferent dosage formDifferent routeNo current shortage

HISTAMINE PHOSPHATE INJECTION USP, 1MG/ML

ALVEDA PHARMACEUTICALS INC

1MG · DIN 02300427

Different strengthDifferent dosage formDifferent routeNo current shortage

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2026-12-31

~3 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

00609692

Strength

2.75MG

Dosage Form

SOLUTION

Route

PERCUTANEOUS

Active Ingredient

HISTAMINE PHOSPHATE

Tier

Unrated

Last Updated

2025-12-08

Reason for Shortage

Shortage of an active ingredient.